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A Case of Exercise-induced Acute Renal Failure with G774A 
Mutation in SCL22A12 Causing Renal Hypouricemia
Acute renal failure with severe loin pain which develops after anaerobic exercise is rare. 
One of predisposing factors of exercise-induced acute renal failure is renal hypouricemia. 
Idiopathic renal hypouricemia is a genetic disorder characterized by hypouricemia with 
abnormally high renal tubular uric acid excretion. The mutation in SCL22A12 gene which 
encodes renal uric acid transporter, URAT1, is the known major cause of this disorder. We 
here described a 25-yr-old man showing idiopathic renal hypouricemia with G774A 
mutation in SCL22A12 who presented exercise-induced acute renal failure. There have 
been a few reports of mutational analysis in Korean idiopathic renal hypouricemia without 
acute renal failure. This is the first report of genetically diagnosed idiopathic renal 
hypouricemia with exercise-induced acute renal failure in Korea.
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CASE REPORT
Nephrology
INTRODUCTION
Exercise-induced acute renal failure (ARF) usually reflects mas-
sive rhabdomyolysis. On the other hand, ARF with severe loin 
pain and normal or only slightly elevated concentrations of cre-
atine phosphokinase and serum myoglobin can develop after 
anaerobic exercise (1). Idiopathic renal hypouricemia is a genet-
ic disorder attributed to increased renal excretion rates of urate, 
which reduces serum uric acid concentration (2). Exercise-in-
duced ARF associated with renal hypouricemia was first report-
ed in 1989 (3), and the majority of cases have been reported in 
Japanese and non-Ashkenazi Jews (4). The incidence of renal 
hypouricemia has been reported to be 0.12%-0.72% (5, 6). Al-
though most of the patients with renal hypouricemia are asymp-
tomatic, exercise-induced ARF and nephrolithiasis may be the 
complications. The mutation at SLC22A12 gene which encodes 
renal uric acid transforter, URAT1, is the known major cause of 
this disorder. Here we report a case of exercise-induced ARF with 
URAT1 gene mutation causing renal hypouricemia.
CASE DESCRIPTION
On July 30, 2010, a 25-yr-old man was admitted to our hospital 
because of bilateral loin pain and nausea just after severe physi-
cal activity, and that was 2nd episode since 1 month before. He 
had played football and jogging on a regular base since he was 
20 yr old, but there was no problem. He had completed military 
service in Korea without any medical problem. Five days prior 
to his visit, he had run thousands of meters for an employment 
test of a local security company. Just after the test, he got vomit-
ing and loin pain. He endured the symptoms for a few days, but 
oliguria developed the day before he was admitted. He had ex-
perienced same symptoms after same physical activity test, 1 
month ago. On admission, he had oliguria. Height and weight 
were 171 cm and 81 kg. Blood pressure was 143/85 mmHg and 
body temperature was 36.3°C. Physical examination did not re-
veal any abnormalities except bilateral costovertebral angle ten-
derness. Laboratory tests showed the following: hemoglobin 12.6 
g/dL, hematocrit 35.9%, leukocyte count 6,160/μL with normal 
differentiation, platelet 209,000/μL, total protein 6.7 g/dL, serum 
sodium 139 mEq/L, potassium 4.4 mEq/L, chloride 107 mEq/L, 
BUN/Cr 29.0/4.31 mg/dL, CK/LDH 87/259 U/L, CRP 1.24 mg/
dL, uric acid 2.0 mg/dL, spot urine sodium 45 mEq/L, urine myo-
globin(-), 24-hr urine sodium 179 mM/day, potassium 3 mM/
day, chloride 231 mM/day, uric acid 517 mg/day, Cr 1.68 g/day, 
fractional excretion of sodium 4.6%, and fractional excretion of 
uric acid 66%. The kidney sonographic image showed left kid-
ney/right kidney 12.3/12.9 cm and no abnormal echo texture. 
After 9 days of admission, marked hypouricemia became appar-
ent with the improvement of renal function: BUN was 18.4 mg/
dL, serum creatinine 1.66 mg/dL, and serum uric acid 1.4 mg/
dL. Gene analysis was done under the diagnosis of exercise-in-
duced ARF associated with idiopathic renal hypouricemia. Pe-
ripheral blood sample for gene analysis was obtained from the 
patient. DNA sequence analysis of the exon 1, 3, and 4 (hot spot 
for mutations) of the URAT1 gene was undertaken. Gene analy-
sis revealed a homozygous nonsense mutation (c.G774A, p.Trp-
258Stop) in the exon 4 of the URAT1 gene (Fig. 1). After 11 days Kim YH, et al.  •  Exercise-induced Acute Renal Failure with Renal Hypouricemia
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of admission, he was discharged with the improvement of renal 
function (BUN 17.1 mg/dL, serum creatinine 1.14 mg/dL).
 
DISCUSSION
Uric acid is the end product of the metabolism of purine com-
pounds. Contrary to the vast majority of mammalian species, 
the human homolog of the mammalian uricase gene is structur-
ally modified to an unexpressed (pseudogene) state. As a result, 
normal humans have serum urate concentrations approaching 
the theoretical limit of solubility of urate in serum (6.8 mg/dL). 
With the exception of minor non-specific contributions from 
peroxidases and catalases, human tissues do not have the abili-
ty to metabolize urate. Thus, in order to maintain homeostasis, 
urate must be eliminated by the gut and the kidney. Hypourice-
mia is defined as serum uric acid level below 2 mg/dL. This can 
be the result from the condition which uric acid production de-
creases. But more commonly, it results from increased renal uric 
acid excretion (2). The causes of increased urate clearance in-
clude medications with uricosuric properties, total parenteral 
hyperalimentation, and defects in renal tubular transport such 
as Fanconi syndrome. Some cases of familial hypouricemia re-
sult from a loss-of-function mutation in SLC22A12, the gene that 
encodes for URAT1. 
  The pathogenesis and clinical details of ARF associated with 
renal hypouricemia remain unknown. In 2002, Ishikawa (1) re-
ported two types of exercise-induced ARF: one is the well-known 
myoglobin-induced ARF, and the other is new type of ARF with 
severe loin pain which develops after anaerobic exercise (ALPE). 
ALPE develops after anaerobic exercise such as 200-meter track-
ing racing. The patient in this case who ran hundred meters with-
out rest also developed ALPE. The relationship between hypou-
ricemia and ALPE is not fully understood. However, recently a 
urate/organic anion exchanger (URAT1) has been identified and 
characterized (7, 8). The URAT1 is a highly urate-specific and 
distinct organic anion exchanger and is encoded by SLC22A12, 
a gene residing on chromosome 11q13. A defect in the SLC22A12 
gene is the known major cause of idiopathic renal hypouricemia. 
Most patients with idiopathic renal hypouricemia have loss-of-
function mutations in SLC22A12. Although many different mu-
tations have been reported in SLC22A12, W258X and R90H are 
the common mutations in Korea (9-11). In our case, 258th ami-
no acid substituted guanine to adenine, which means stop co-
don resulting from a homozygous nonsense mutation (c.G774A, 
p.W258X) in the exon 4 of the URAT1 gene (Fig. 1).
  Uric acid is a powerful antioxidant, and is a scavenger of oxy-
gen free radicals (12) which has been suggested to injure neph-
ron segments, especially proximal tubules. In patients with renal 
hypouricemia, the uric acid pool is very small, the static intracel-
lular concentration of uric acid is low, and the total amount of 
uric acid mobilized into proximal tubular cell is also very small, 
although the daily urinary excretion of uric acid is usually nor-
mal (13). During exercise, the production of oxygen free radicals 
increases, and the increase of muscular blood flow results in the 
decrease of renal blood flow (14, 15). This phenomenon may 
lead to severe vasoconstriction in patients with hypouricemia, 
which is likely to occur when the intracellular concentration of 
uric acid is low (13). In addition, oxygen free radicals may be over-
produced after the recovery of renal blood flow in patients with 
severe vasoconstriction compared to those in healthy people, as 
shown in ischemia-reperfusion models (16, 17). For these rea-
sons, patients with renal hypouricemia may be prone to develop 
ARF. There was a seasonal/monthly variation in the occurrence 
of ARF according to 54 renal hypouricemia induced ARF patients 
survey in Japan (18). In that study, ARF episodes were found to 
occur predominantly in May, September and October. This trend 
was especially marked in patients who had ARF episodes in-
duced by short distance racing. The seasonal/monthly variation 
seems to coincide with the months in which most athletic meet-
ings are held in Japan. Therefore, ARF in hypouricemic patients 
may be associated with specific exercise such as short-distance 
races. In our case, the patient had no specific symptoms after 
aerobic exercise such as jogging or soccer, but ARF developed 
after severe anaerobic exercise. This can be explained by isch-
emia-reperfusion models. 
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